Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:292 (31 July), doi:10.1136/bmj.329.7460.292-b
| The first 150 words of the full text of this article appear below. |
|
|
Credit: MORRY GASH/AP
|
EDITORThe grandiose scale of George W Bush's mental health initiative makes it difficult to comment on the "road" he wishes to take, or to relate this American proposal to the recent British report on mental health and social exclusion.1 2 The devil is in the detail. Because of the longstanding mutual interests of the pharmaceutical industry and this presidency, the remorseless pressure of Big Pharma on doctors and patients spreads far beyond the United States to policy and planning across the world's health economies.3 4
None the less, the United Kingdom can learn from the American population perspective that schools "are in a `key position' to screen the 52 million students."1 Big Pharma has an interest in screening to label more mental illness that can introduce millions of new child "consumers" to maintenance psychotropic treatment. But schools can also provide promising opportunities for promoting mental health across
Woody Caan, professor of public health
Department of Public and Family Health, APU, Chelmsford, Essex CM1 1SQ a.w.caan@apu.ac.uk